Pharmacoeconomics hospital based on Information Technology
Science Articles / / May 09, 2016
Groisman VA, Soboleva OA
problem pharmacoeconomic studies in health care has become a priority because of the difficulties with budgetary financing.Market conditions of the Russian economy, facilitate the transition of health care funding to the budget for funding, paid by health insurance funds, as well as by the patients themselves.There is a problem of quality health care at a deficit of funds.
use of pharmacoeconomic methods is becoming a prerequisite for solving various problems of providing medical help, the purpose of which is the selection of drug therapy for each patient from the standpoint of better effect with a minimum of wasted resources.
In this regard, we, in our hospital set a goal to use existing methods of pharmacoeconomic analysis with a description of their components and application in our hospital.
to economic evaluation provides a mechanism for the efficient allocation of scarce resources, it is necessary to compare both the cost and the results of treatment with other f
But there are provisions whose implementation is mandatory.First of all, is to follow the standards of treatment of separate nosological forms of diseases and drug formulary, designed for a particular disease.But sometimes these requirements are not feasible due to limited financial resources.Therefore, for our hospital urgent task justify the amount of money that is needed for the treatment of patients for the planning period that will allow the allocation of funds allocated to reserve amount for a particular disease patients.
Based on this, the basic principles of pharmacoeconomics, we believe rationality, justice and conclusiveness.
rationality principle implies:
- the provision of pharmaceutical care within available resources (which are limited to our hospital budget).
- use of funds that is necessary in the first place.
- the need to pay only the effective interventions that have the best ratio "cost - effectiveness".
justice principles include:
- equal access to effective assistance;
- a systematic review;
- controlled randomized trials;
- opinion and experts.
for systematization and centralization of information processing software was developed, which served as a basis for studying the structure of the claimed range of medicines and medical products.
All medical products for the analysis generated by pharmacotherapeutic groups:
- drugs (LS);
- medical products (medical devices) (dressings, adhesive plasters, rubber products sanitation and hygiene, medical devices made of polymeric materials);
- immunobiological preparations (IBMP) - vaccines, serums, etc .;
- reagents, clinical diagnostic kits, diagnostic diagnostic paper, utensils and tools for laboratory work;
- other medical products (sutures, etc..).
On the basis of the findings of the range of the structure and cost savings have been made by preventing the waste of resources due to the specific program. ( Analysis for the year 2003).
largest share in the total volume of medical products are drugs 62.3% in value terms.
In second place - medical devices (medical products) to 26.1%, further reagents, clinical diagnostic kits, 9.2% and other 2, 4%.
ratio of medical products of domestic and foreign production in the total volume in value terms respectively reached 51.3% and 48.7%.
ratio medicines list VED (Vital and Essential Medicines) domestic and foreign production in general, the volume amounted to 39,8% and 60,2%
Based willows this we can conclude about the dominant position of the domestic health care products in the hospital,but drugs VED major share of foreign products.
According to the number of entries in the application form in the lead "Antibiotic drugs penicillin and cephalosporins" (share of the order of 11.9%), "Other antibiotic drugs» (8,7%). |"Dressings and plasters" (5.6%).
In the analysis of drugs on the number of units occupied by the stated natural antibiotics - ampicillin n / a vial.500 ml. ,null, Gentamicin sulfate fl.0,08 g .;ampioks sodium vials. 500 ml.
However, analyzing the data of recent years, the trend of growth drugs cephalosporin (ceftazidime, Fortum, 1 vial, at tsrfoperazon-sulperazon, fl 2.0 tsefatoksim-tsefatoksim sodium vials 1 g;.... Cefazolin-kefzol,fl. 1) and substituted penicillins (augmentin), ienew, highly effective drugs .
We understand that additional investments are valued in monetary terms, but additional benefits can be measured by a variety of indicators.Therefore these advantages evaluation criteria for direct analyzes clinical effects (this shift of physiological and biochemical parameters change symptoms and so on.), As well as final: changing health parameters.
Therefore pharmacoeconomic studies in demand in our hospital to solve the following problems:
- valuation of drug therapy, the determination of its share in the total costs;
- comparison drug therapy costs with outcomes of medical interventions;
- study drugs of choice for the development of regulations to ensure their rational use;
- justification for the purchase of medicines for the needs of our hospital.
By analyzing the characteristics of pharmacoeconomic drug, in the appointment of their doctors in our hospitals of paramount importance given the effectiveness of the drug (75%), followed by safety (40% ) and only on the 3rd place was the price.Fig.1.
If our suppliers have established a long and stable relationship, and their products are not too expensive, then we buy it on credit.If an expensive drug, then we buy it for a specific patient and immediately paying the price.
The pharmacy portfolio is both expensive and cheap products.Despite the fact that the rise in prices of medicines began to slow down, but the analysis shows that prices remain high.Fig.2.
A lack of funding affects the volume of purchases.
We tried to analyze the range of medicines, claimed our hospital, constantly monitor his condition.
objective assessment of the effectiveness of the claimed medicinal products, the introduction of our methods for pharmacoeconomic analysis software allows us to further prioritize the procurement of medicines, ensuring their constant presence in the hospital, which greatly improve the provision of medicines inpatients.
29 May, 2016
29 May, 2016